MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Association of Increased Frontal White Matter A2A Receptor Availability with Decreased Frontal Gray Matter Volume in Patients with Parkinson’s Disease

    I. Waggan, E. Rissanen, J. Tuisku, M. Matilainen, R. Parkkola, J. Rinne, L. Airas (Turku, Finland)

    Objective: We sought to investigate in vivo changes in A2A receptor availability in cerebral white matter of PD patients and its association with gray matter…
  • 2023 International Congress

    Frequency of SCA 2, 3 and 7 in Slovak patients with spinocerebellar ataxia – first report of SCA2 patient from Slovakia

    M. Ostrozovicova, V. Turchetti, M. Rizig, J. Necpal, V. Han, Z. Gdovinova, H. Houlden, M. Skorvanek (Kosice, Slovakia)

    Objective: The aim of this study is to investigate the frequency of spinocerebellar ataxia (SCA) 2, 3 and 7 among Slovak patients with cerebellar ataxia…
  • 2023 International Congress

    Unusual Neuronal Intranuclear Inclusion Disease (NIID) with initial presentation mimicking recurrent Transient Global Amnesia (TGA)

    S. Kim, WT. Yoon (Seoul, Republic of Korea)

    Objective: Our aim is to report an unusual Neuronal intranuclear inclusion disease (NIID) case of a woman who initially presented recurrent Transient Global Amnesia (TGA)…
  • 2023 International Congress

    3D Multi-Delay pCASL to Understand Perfusion Changes in Patients with Parkinson’s disease with Mild Cognitive Impairment

    B. Thomas, Z. Mari, V. Mishra (Dallas, USA)

    Objective: To understand perfusion changes in patients with Parkinson’s disease (PD) with well-characterized mild cognitive impairment (MCI) using 3D multi-delay pseudo-continuous Arterial Spin Labeling (pCASL)…
  • 2023 International Congress

    Exercise and levodopa metabolism in Parkinson disease

    M. Figura, J. Giebułtowicz, A. Mrozowicz, S. Szlufik, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of our paper was to assess if standard physical exercise may change pharmacokinetics of levodopa/benserazide in patients with and without prior exposure…
  • 2023 International Congress

    Asymmetry and side concordance of rest tremor and bradykinesia in patients with essential tremor

    L. Angelini, G. Paparella, D. Costa, D. Birreci, A. Cannavacciuolo, M. Passaretti, D. Colella, A. Berardelli, M. Bologna (Rome, Italy)

    Objective: In the present study, we aimed to investigate the clinical and kinematic features of rest tremor and bradykinesia in patients with essential tremor (ET),…
  • 2023 International Congress

    Actigraphy wear compliance across CNS disorders

    J. Lavine, A. Pearlmutter, K. Momeni, R. Ellis (New York, USA)

    Objective: Examine actigraphy wear compliance in 5 neurological-disorders clinical trials using an ActiGraph GT9X Link with additional compliance features Background: Wrist worn biometric devices are…
  • 2023 International Congress

    Does the dopaminergic pathway interfere with the sustained CSF tap test effect in normal-pressure hydrocephalus?

    H. Onder, T. Comoglu, S. Comoglu (Ankara, Turkey)

    Objective: To discuss the possible dopaminergic pathway interference as a mechanism underlying the sustained benefit of the CSF tap test in NPH. Background: The sustained…
  • 2023 International Congress

    Patterned alternating-coloured strips for freezing of gait – Novel solution for a disabling symptom.

    M. Matta, N. Sawal, D. Bansal (Chandigarh, India)

    Objective: To evaluate a novel method of visual cueing using patterned alternating-coloured strips made of electrical tape for freezing of gait. Background: Freezing of gait…
  • 2023 International Congress

    Huntington’s disease-like 2 phenotypes: a case series from a Brazilian referral center

    C. Candeias, G. Santos, M. Costa, A. Pessoa Neto, F. Sarmento, B. Veiga, R. Saba, V. Tumas, S. Silva, V. Borges, H. Ferraz (Sao Paulo, Brazil)

    Objective: To describe the clinical phenotypes of Huntington’s disease-like 2 patients in a referral movement disorders (MD) center in Brazil. Background: Huntington's disease-like 2 (HDL2)…
  • « Previous Page
  • 1
  • …
  • 616
  • 617
  • 618
  • 619
  • 620
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley